Drugs / Meningococcal B Recombinant vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02946385 | Nov 2016 → Feb 2018 | meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal B Recombinant vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02946385 ↗ |
| Modality | Vaccine | “Meningococcal B Recombinant vaccine” NCT02946385 ↗ |